Replay launches big DNA HSV gene therapy company, Telaria, focused on rare skin diseases
21 nov. 2022 07h00 HE
|
Replay Bio
Replay launches big DNA HSV gene therapy company, Telaria, focused on rare skin diseases Second product company using Replay’s next-generation high payload capacity HSV delivery vector developed at...